HLB Life Science Co., Ltd. (KOSDAQ: 067630)

HLB Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,152,887	1,165,599	1,077,864	1,188,951	1,280,316	1,305,844
Market Cap Growth	38.44%	8.14%	-9.34%	-7.14%	-1.95%	109.16%
Enterprise Value	1,204,476	1,260,366	1,030,778	1,020,209	1,153,412	1,255,129
Last Close Price	9720.00	11155.39	10327.26	11533.40	12598.74	12853.49
PE Ratio	14.47	-	-	-	-	-
PS Ratio	10.59	11.90	10.82	22.23	13.95	11.45
PB Ratio	2.66	5.04	4.57	4.82	4.45	3.90
P/TBV Ratio	3.39	6.66	7.52	6.48	6.10	5.50
P/OCF Ratio	-	-	-	-	636.96	-
EV/Sales Ratio	12.40	12.86	10.35	19.07	12.56	11.01
EV/FCF Ratio	-20.52	-	-	-	-	-
Debt / Equity Ratio	0.38	0.72	0.62	0.02	0.04	0.04
Asset Turnover	0.19	0.23	0.29	0.18	0.25	0.29
Inventory Turnover	14.55	12.26	16.27	30.72	19.42	16.40
Quick Ratio	1.28	0.68	5.49	11.28	9.85	5.42
Current Ratio	1.36	0.73	6.00	11.59	10.15	5.61
Return on Equity (ROE)	21.64%	-2.53%	-22.52%	-18.45%	-17.95%	-2.80%
Return on Assets (ROA)	-3.36%	-3.81%	-3.65%	-3.83%	-1.37%	-0.87%
Return on Capital (ROIC)	-3.48%	-4.08%	-3.93%	-4.16%	-1.55%	-1.04%
Earnings Yield	6.91%	-0.51%	-5.04%	-4.13%	-4.36%	-0.58%
FCF Yield	-5.09%	-2.63%	-3.75%	-1.39%	-0.50%	-1.64%
Buyback Yield / Dilution	-0.22%	-0.80%	-1.64%	-0.34%	-6.39%	-54.49%
Total Shareholder Return	-0.22%	-0.80%	-1.64%	-0.34%	-6.39%	-54.49%

Source: S&P Capital IQ. Standard template. Financial Sources.